Contact: Sarah Avery sarah.avery@duke.edu 919-660-1306 Duke University Medical Center DURHAM, N.C. – A large study addressing the effectiveness and safety of aldosterone antagonist therapy for older heart failure patients has found notable differences between the drug's results in clinical trial vs. what occurs in actual practice, according to researchers at Duke Medicine. Those differences have…
Intensive medication optimization cost-effective in patients hospitalized with HFrEF healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Were the GLP-1 receptor agonist drug s apparent benefits in STEP-HFpEF due solely to weight loss or additional mechanisms? The trial offers a clue, experts say.
Four experts explain nuances of the multidrug strategy and why it should be easy to implement. Given its slow uptake in practice, what forces are conspiring against it?